Skip to content

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

Home
Pharma applications
Non-pharma applications
CD derivatives
Events
E-ducation

Tag: NACC

December 5, 2025 Events

First virtual meetup of North American Cyclodextrin Consortium (NACC)

The North American Cyclodextrin Consortium (NACC) will host its first virtual meetup on December 11 at 10:00 AM PST (add

Continue reading

Search for:

Recent Posts

Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
Cyclodextrins hit the golf course seven years ago — and they are still there
Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

LinkedIn
X
Facebook

Categories

Agriculture (27)
Analysis (73)
CD as API (355)
CD derivatives (431)
Cosmetics and toilettry (54)
Diagnosis (15)
Drug delivery (816)
E-ducation (63)
Environmental (143)
Events (239)
Food (233)
Gene delivery (22)
Household products (6)
In Hungarian (4)
Life sciences (45)
Non-pharma applications (416)
Other industrial use (112)
Pharma applications (1,219)
Supramolecular systems (44)
Uncategorized (167)

Top Posts

Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
22nd International Cyclodextrin Symposium (ICS-22) in India
Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment
Lanosterol eye drops for cataract treatment
Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products
Smart Materials and Surfaces - SMS 2026 International Conference

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 4,476 other subscribers

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website